Core Laboratories NV (CLB)

Currency in USD
14.59
-2.71(-15.66%)
Real-time Data·
CLB is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
14.2116.05
52 wk Range
9.7220.36
Key Statistics
Prev. Close
17.3
Open
16.05
Day's Range
14.21-16.05
52 wk Range
9.72-20.36
Volume
398.52K
Average Vol. (3m)
392.61K
1-Year Change
43.0887%
Book Value / Share
5.71
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
CLB Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
16.33
Upside
+11.95%
Members' Sentiments
Bearish
Bullish
ProTips
Has maintained dividend payments for 19 consecutive years

Core Laboratories NV News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Sell
Moving Averages
Strong Sell

Analyst Ratings

1 Buy
1 Hold
1 Sell
Ratings:
3 analysts
Overall Consensus
Neutral

Analysts 12-Month Price Target:

Average 16.33
(+11.95% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Citi
Hold12.00-16.43%13.00MaintainOct 10, 2025
Stifel
Hold12.00-16.43%13.00MaintainJul 16, 2025
Citi
Hold13.00-9.47%16.00MaintainMay 13, 2025

Core Laboratories NV Earnings Call Summary for Q1/2026

  • Q1 2026 EPS of $0.06 missed forecast of $0.26 by 77%; revenue fell 12% sequentially to $121.8M, down 1% year-over-year
  • Stock plunged 14.28% to $17.30 after-hours on disappointing results; geopolitical disruptions and severe weather impacted operations
  • Net income dropped 72% sequentially to $2.7M; rising raw material and logistics costs pressured margins amid operational challenges
  • Company projects EPS recovery to $0.15 in Q3 2026 and $0.20 in Q4 2026; focusing on digital transformation and RAPID platform expansion
  • CEO Demshur emphasized navigating geopolitical risks while strengthening diagnostic services; Gulf of Mexico demand remains robust
Last Updated: 04/30/2026, 09:55 AM
Read Full Transcript

Earnings

Latest Release
Apr 29, 2026
EPS / Forecast
0.06 / 0.26
Revenue / Forecast
121.8M / --
EPS Revisions
Last 90 days

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 0.63%
Dividend Yield
0.23%
Industry Median 1.39%
Annualized Payout
0.04
Paid quarterly
5-Years Growth
-32.24%
Growth Streak

CLB Income Statement

Compare CLB to Peers and Sector

Metrics to compare
CLB
Peers
Sector
Relationship
P/E Ratio
27.4x24.5x6.6x
PEG Ratio
−5.910.100.00
Price / Book
2.9x1.7x1.1x
Price / LTM Sales
1.5x1.4x1.6x
Upside (Analyst Target)
−13.3%−2.0%13.3%
Fair Value Upside
Unlock11.5%3.4%Unlock

Core Laboratories Inc. provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and natural gas from its clients' reservoirs. It offers laboratory-based analytical and field services to characterize properties of crude oil and oil delivered products; and proprietary and joint industry studies, as well as services that support carbon capture, utilization and storage, geothermal projects, and the evaluation and appraisal of mining activities. The Production Enhancement segment provides services and products relating to reservoir well completions, perforations, stimulations, production, and well abandonment. It offers integrated diagnostic services to evaluate and monitor the effectiveness of well completions and to develop solutions to improve the effectiveness of enhanced oil recovery projects. The company markets and sells its products through a combination of sales representatives, technical seminars, trade shows, and print advertising, as well as through distributors. Core Laboratories Inc. was founded in 1936 and is based in Houston, Texas.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
26.89M58.39%465.19M
Other Institutional Investors
24.95M41.61%431.58M
Public Companies & Retail Investors
0.000.00%0.00
Total
51.84M100.00%896.77M

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Ariel Investments, LLC29.67%13,661,000236,335
BlackRock, Inc.15.53%7,153,543123,756

People Also Watch

21.83
RELY
-0.27%
116.97
ETR
+2.01%
185.85
CHRW
-0.31%
314.07
NSC
+0.62%
247.58
VLO
-1.48%

FAQ

What Is the Core Laboratories (CLB) Stock Price Today?

The Core Laboratories stock price today is 14.59 USD.

What Stock Exchange Does Core Laboratories Trade On?

Core Laboratories is listed and trades on the New York Stock Exchange.

What Is the Stock Symbol for Core Laboratories?

The stock symbol for Core Laboratories is "CLB."

Does Core Laboratories Pay Dividends? What’s The Current Dividend Yield?

The Core Laboratories dividend yield is 0.23%.

What Is the Core Laboratories Market Cap?

As of today, Core Laboratories market cap is 654.35M USD.

What Is Core Laboratories's Earnings Per Share (TTM)?

The Core Laboratories EPS (TTM) is 0.63.

When Is the Next Core Laboratories Earnings Date?

Core Laboratories will release its next earnings report on Jul 29, 2026.

From a Technical Analysis Perspective, Is CLB a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Core Laboratories Stock Split?

Core Laboratories has split 2 times.

How Many Employees Does Core Laboratories Have?

Core Laboratories has 3300 employees.

What is the current trading status of Core Laboratories (CLB)?

As of Apr 30, 2026, Core Laboratories (CLB) is trading at a price of 14.59 USD, with a previous close of 17.30 USD. The stock has fluctuated within a day range of 14.21 USD to 16.05 USD, while its 52-week range spans from 9.72 USD to 20.36 USD.

What Is Core Laboratories (CLB) Price Target According to Analysts?

The average 12-month price target for Core Laboratories is 16.33 USD, with a high estimate of 22 USD and a low estimate of 12 USD. 1 analysts recommend buying the stock, while 1 suggest selling, leading to an overall rating of Neutral. The stock has an +11.95% Upside potential.

What Is the CLB Premarket Price?

CLB's last pre-market stock price is 17.00 USD. The pre-market share volume is 1,500.00, and the stock has decreased by -0.30, or -1.73%.

What Is the CLB After Hours Price?

CLB's last after hours stock price is 17.50 USD, the stock has decreased by 0.20, or 1.16%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.